Intrinsic Value of S&P & Nasdaq Contact Us

Cue Biopharma, Inc. CUE NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
60/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.33
+888.6%

Cue Biopharma, Inc. (CUE) has 12 identified peers for comparison in the Healthcare sector. Peers include ANIX, CGTX, COYA, DAWN, DRMA, ELYM and others.

CUE has a market capitalization of $34.53M, compared to an average peer market cap of $255.66M. CUE is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message